Gene Therapy Offers Breakthrough Cure for Sickle Cell in U.S. – TV360
Source Link
Excerpt:
In a significant medical breakthrough, A 21-year-old man from Laurelton, Long Island, Sebastien Beauzile, has become the first person in New York State to be cured of sickle cell anemia through groundbreaking Lyfgenia gene therapy.
Administered at Cohen Children’s Medical Center, this innovative treatment offers new hope for those suffering from the debilitating disease.
Beauzile’s battle with sickle cell anemia began at just four months old, marked by frequent hospitalizations due to extreme pain crises.
Describing the agony as unbearable, he faced a lifetime of challenges with little respite. But in 2024, everything changed when he underwent Lyfgenia gene therapy, a revolutionary treatment developed by Bluebird Bio and FDA-approved in December 2023.
Lyfgenia works by using the patient’s own stem cells, modifying them genetically to produce functional hemoglobin, and reintroducing them into the bloodstream.
